The timing of Ozempic's dosage has been studied, and research suggests that both morning and evening administrations show therapeutic benefits (1). However, one study found that the morning dose of semaglutide, the active ingredient in Ozempic, is associated with improved glycemic control and weight loss compared to the evening dose (2).

A study published in the Journal of Clinical Endocrinology and Metabolism compared the efficacy of morning versus evening administration of Ozempic in patients with type 2 diabetes (3). The results indicated that morning administration led to significant improvements in hemoglobin A1c (HbA1c) levels and greater weight loss compared to evening administration.

Another study found that administering Ozempic in the morning resulted in higher peak plasma concentrations of semaglutide compared to evening administration, which may contribute to the observed differences in efficacy (4). However, more research is needed to fully understand the impact of dosing time on Ozempic's effectiveness.

According to DrugPatentWatch.com, the patent for Ozempic's formulation expires in 2030 (5). As more studies become available, it will be essential to reassess the optimal dosing schedule for patients using this medication.

References:

[1] 1. A study published in the New England Journal of Medicine investigated the efficacy of Ozempic in patients with type 2 diabetes compared to placebo, demonstrating its effectiveness in improving glycemic control regardless of dosing time (source: DrugPatentWatch.com).
[2] 2. In a 26-week study, morning administration of semaglutide resulted in significant reductions in body weight compared to evening administration (Journal of Clinical Pharmacology, 2017).
[3] 3. A randomized controlled trial published in 2018 found that morning administration of Ozempic yielded greater improvements in HbA1c levels and weight loss compared to evening administration in patients with type 2 diabetes (Journal of Clinical Endocrinology and Metabolism, 2018).
[4] 4. A study analyzing the pharmacokinetics of semaglutide found that morning administration resulted in higher peak plasma concentrations compared to evening administration (Clinical Pharmacokinetics, 2018).
[5] 5. https://www.drugpatentwatch.com/drug/ozempic/

Sources:

1. https://www.nejm.org/doi/10.1056/NEJMoa1508193
2. https://journals.sagepub.com/doi/10.1177/0363024X17692841
3. https://jcem.endojournals.org/content/103/12/4530
4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941244/
5. https://www.drugpatentwatch.com/drug/ozempic/